Tumor infiltrating lymphocytes: CD8+ lymphocytes in canine transmissible venereal sarcomas at different stages of tumor growth

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 1137-1142

  Barber, Michele R ^a   Yang, T J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Canine; CD8+ lymphocytes; Tumor infiltrating lymphocytes; Venereal sarcomas

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL VENEREAL TUMOR; ARTICLE; DOG; NONHUMAN; PRIORITY JOURNAL; SARCOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTACTIC FACTORS; DOGS; FEMALE; IMMUNOPHENOTYPING; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; NEOPLASM STAGING; SARCOMA, EXPERIMENTAL;

EID: 0032996269     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Topalian SL, Solomon D, and Rosenberg SA: Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142: 3714-3725, 1989.
2. Tanaka H, Shimoda T, Uchida K, Suzuki T, and Ishikawa E: Immunohistochemical study on the distribution and significance of mononuclear cells in human breast carcinomas. Acta Pathol Jpn 36: 1455-1467, 1986.
3. Ioannides CG, Freedman RS, Platsouces CD, Rashed S, and YoungDil K: Cytotoxic T-cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J Immunol 146: 1700-1707, 1991.
4. Donnerstag B, Schroder W, Hoos P, Oltrogge JB, and Bender HG: Interactions between tumor cells and tumor infiltrating lymphocytes in human ovarian carcinoma. Clin Exp ObstetGynecol 21: 153-159, 1994.
5. Rivoltini L, Arienti F, Orazi A, Cefalo G, Gasparini M, Gambacorti-Passerini C, Fossati-Bellani F, and Parmiani G: Phenotypic and functional analysis oflymphocytes infiltrating pediatric tumors, with a characterization of the tumor phenotype. Cancer Immunol Immunother 34: 241-251, 1992.
6. Karidin RL, Lazarus DS, Dubinett SM, Gifford J, Grove B, Kurnick JT, Preffer FI, Pinto CE, Davidson E, Callahan RJ, and Strauss WH: Tumor-infiltrating lymphocytes and interlukin-2 in treatment of advanced cancer. Lancet 18: 577-580, 1989.
7. Whiteside TL, Jost LM, and Herberman RB: Tumor-infiltrating lymphodytes: potential and limitations to their use for cancer therapy. Crit Rev in Oncology/Hematology 12: 25-47, 1992.
8. Rockett JC, Darnton SJ, Crocker J, Matthews HR, and Morris AG: Lymphocyte infiltration in esophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade. J Clin Pathol 49: 264-267, 1996.
9. Watt AG and House AK: Colonic carcinoma: a quantitated assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis. Cancer 41: 279-282, 1978.
10. Wolf GT, Hudson JL, Peterson KA, Miller HL, and McClatchey KD: Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlation's with extent of tumor and prognosis. Otolaryngol Head Neck Surg 95: 142-151, 1986.
11. Poppema S, Brocker EB, deLeij L, Terbrack D, Visscher T, Ter Haar A, Macher E, The TH, and Sorg C: In situ analysis of the mononuclear cell infiltrates in primary malignant melanoma of the skin. Clin Exp Immunol 51: 77-82,
12. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MJ, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartzentruber D, Wei JP, and White DE: Use of tumor-infiltrating lymphocytes and interlukin-2 in the immunothereapy of patients with metastatic melanoma. New Eng J Med 319: 1676-1680, 1988.
13. Aebersold P, Hyatt C, Johnson S, Hines K, Karcak L, Sanders M, Topalian S, Yang J, and Rosenberg S: Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response JNCI 83: 932-937, 1991.
14. Edwards RP, Kuykendall K, Crowley-Nowick P, Partridge EE, Shingleton HM, and Mestecky J: T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. Cancer 76: 1411-1415, 1995.
15. thor Straten P, Becker JC, Seremet T, Brocker EB, and Zeuthen J: Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest 98: 279-284, 1996.
16. Yang TJ: Immunobiology of a spontaneously regressive tumor, the canine transmissible venerealarcoma(review). Anti Cancer Res 8: 93-96, 1988.
17. Yang TJ and Jones JB: Canine transmissible venereal sarcoma: transplantation studies in neonatal and adult dogs. JNCI 51:1915-1918, 1973.
18. Cohen D: Detection of humoral antibody to the transmissible venereal tumour of the dog. Int J Cancer 10: 207-212, 1972.
19. Yang TJ, Palker TJ, and Harding MW: Tumor size, leukocyte adherence inhibition, and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma. Cancer Immunol Immunother 33: 255-262, 1991.
20. Palker TJ and Yang TJ: Identification and physiochemical characterization of a tumor associated antigen from canine transmissible venereal sarcoma. JNCI 66: 779-787, 1981.
21. Yang TJ, Chandler JP, and Dunne-Anway S: Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma. Br J Cancer 55: 131-134, 1987.
22. Hill DL, Yang TJ, and Wachtel A: Canine transmissible venereal sarcoma: Tumor cell and infiltrating leukocyte ultrastructure at different growth stages. Vet Pathol 21: 39-45, 1984.
23. Trail PA and Yang TJ: Canine transmissible venereal sarcoma: quantitation of T-lymphocyte subpopulations during progressive growth and spontaneous tumor regression. JNCI 74: 461-467, 1985.
24. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
25. Bevilacque MP: Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11: 767-804, 1993.
26. Larson RS and Springer TA: Structure and function of leukocyte integrins. Immunol Rev 114: 181-217, 1990.
27. Picker LJ: Control of lymphocyte homing. Curr Opin in Immunol 6: 394-396, 1994.
28. Schall TJ: The Chemokines. In: The Cytokine Handbook (Thompson A, ed). New York, Academic Press, 1994, p.419.
29. Gebhard DH and Carter PB: Identification of canine T-lymphocyte subsets with monoclonal antibodies. Vet Immun and Immunopath 33: 187-199, 1992.
30. Yang TJ: Non-gradient regional differences in tumor growth. In vivo 1: 53-56, 1987.
31. Boyden S: Chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 115: 453-459, 1962.
32. McGovern VJ, Shaw HM, Milton CW, and Fargo GA: Prognostic significance of the histological features of malignant melanoma. Histopathology 3: 385-393, 1979.
33. Black MM, Barclay TH, and Hankey BF: Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 36: 2048-2055, 1975.
34. Black MM, Freeman C, Mork T, Harvei S, and Cutler SJ: Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph node. Cancer 27: 703-711, 1971.
35. Bennet SS, Futrell JW, Rath JA, Hoye RC, and Kechem A: Prognostic significance of histologic host response in cancer of the larynx or hypolarynx. Cancer 28: 1255-1265, 1971.
36. Lauder I and Aderne W: The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 26: 321-330, 1972.
37. Chandler JP and Yang TJ: Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes, and tumours at different stages of growth. Br J Cancer 44: 514-521, 1981.
38. Nakanishi H, Monden T, Morimoto H, Kobayashi T, Shimano T, and Mori T: Perforin expression in lymphocytes infiltrated to human colorectal cancer. Br J Cancer 64: 239-242, 1991.
39. Ditonno P, Tso CL, deKernion JB, and Belldegrun GG: Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes. Urol Res 20: 205-210, 1992.
40. Papamichail M and Baxevanis CN: Gamma-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes. J Chemother 4: 387-393, 1992.
41. Sander B and Boeryd B: Tumor necrosis factor-alpha expression in human primary malignant melanoma and its relationship to tumor infiltration by CD3+ cells. Int J Cancer 66: 42-47, 1996.
42. Ezaki K, Suzuki M, Miyazaki H, Maruyama F, Sobue R, Okamoto M, Matsui T, Ino T, Hirano M, et al: Mixed lymphocyte-autologous tumor cell reaction in hematological malignancies-effect of interferon-beta and correlation with the expression of MHC class I antigen on tumor cells. J Interferon Res 11: 305-310, 1991.
43. Jinquan T, Larsen CG, Gesser B, Matsushima K, and Thestrup-Pederson K: Regulation of human T-lymphocyte chemotaxis in vitro by T-cell derived cytokines IL-2, IFN-gamma, IL-4, IL-10, and IL-13. J Immonol 154: 3742-3752, 1995.
44. Jinquan T, Larsen CG, Gesser B, Matsushima K, and Thestrup-Pedersen K: Human interleukin 10 is a chemoattractant for CD8+ T-lymphocytes and an inhibitor of CD4+ T-lymphocyte migration. J Immunol 151: 4545-4551, 1993.
45. Richter G, Kruger-Krasagakes S, Hein G, Hules C, Schmitt E, Diamantstein T, and Blankenstein T: Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 53: 4134-4137, 1993.